secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0001641172-25-002074
Event type: leadership
Sentiment:  negative
Materiality: 0.85
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical shareholders approve reverse split; CEO Michelle Berrey and multiple directors resign
--------------------------------------------------------------------------------

- CEO Michelle Berrey resigned; also resigned as director along with Jack Elias, Bill Owens, Suren Ajjarapu, Amy Griffith.
- Stockholders approved reverse stock split in range of 1:2 to 1:250 (43.7M for, 15.8M against).
- Elected directors: Chirinjeev Kathuria (28.5M for), Elizabeth Ng (30.3M), Jonathan Kurtis (30.6M), Michael Peterson (30.5M).
- 2025 Equity Compensation Plan approved (28.8M for, 4.1M against).
- Non-binding say-on-pay frequency set to three years (27.2M for three years, 3.2M for two, 1.8M for one).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000164117225002074/0001641172-25-002074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000164117225002074/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-002074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer